Related Experiment Videos
Refilling drug delivery depots through the blood
Yevgeny Brudno1, Eduardo A Silva2, Cathal J Kearney3
1Wyss Institute for Biologically Inspired Engineering, Harvard University, Boston, MA 02115; School of Engineering and Applied Sciences, Harvard University, Cambridge, MA 02138;
Summary
Researchers developed a novel method to noninvasively refill drug delivery depots using blood-borne payloads. This targeted refilling technique successfully inhibited tumor growth, offering a new approach for cancer therapy and other applications.
Area of Science:
- Biomedical Engineering
- Nanotechnology
- Drug Delivery Systems
Background:
- Local drug delivery depots are clinically useful but lack noninvasive refilling methods.
- Nanotherapeutics demonstrate tissue-targeting capabilities, inspiring new delivery strategies.
Purpose of the Study:
- To investigate the feasibility of refilling hydrogel drug delivery systems noninvasively using blood-borne drug payloads.
- To develop a sequence-targeted refilling mechanism for drug depots.
Main Methods:
- Hydrogels were modified with oligodeoxynucleotides (ODNs) to act as targets.
- Drug payloads were attached to complementary ODN-carrying alginate strands.
- In vitro and in vivo studies assessed the binding and refilling efficiency of the modified payloads.
Main Results:
- ODN-modified alginate strands specifically bound to complementary-ODN-carrying hydrogels in vitro and in vivo.
- Sequence-targeted refilling of intratumor hydrogels with drug payloads completely inhibited tumor growth.
- Demonstrated successful noninvasive refilling of a drug delivery depot.
Conclusions:
- A new paradigm for nanotherapeutic drug delivery using sequence-targeted refilling has been established.
- This approach holds promise for applications in cancer therapy, wound healing, and vascular grafts.